ResMed Inc. (RMD) is listed on NYSE in Medical Device Stocks. It is $240.31, +1.93%, with a $34.7B market cap. RSI is 72.0, overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 72.0 Overbought
Market Cap $34.7B
Volume 1.1M
Fundamentals — 10-K FY 2026
Revenue $5.7B
Net Income $1.5B
EPS $10.43
Gross Margin 61.1%
Operating Margin 33.4%
Net Margin 26.9%
Debt / Equity 0.1x
P/E Ratio 23.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Farrell Michael J. | Chairman and CEO | Sell | 4,991 | $205.69 | $1.0M | 2026 Aug 7 |
| Farrell Peter C | Director | Sell | 8,000 | $225.00 | $1.8M | 2026 Aug 5 |
| Farrell Michael J. | Chairman and CEO | Sell | 4,991 | $218.55 | $1.1M | 2026 Jul 7 |
| Farrell Michael J. | Chairman and CEO | Sell | 4,991 | $193.96 | $968,064 | 2026 Jun 8 |
| Farrell Michael J. | Chairman and CEO | Sell | 4,991 | $207.82 | $1.0M | 2026 May 7 |
| Farrell Michael J. | Chairman and CEO | Sell | 4,991 | $225.50 | $1.1M | 2026 Apr 7 |
| Sandercock Brett | Chief Financial Officer | Sell | 1,000 | $224.31 | $224,310 | 2026 Apr 1 |
| Farrell Peter C | Director | Sell | 2,000 | $225.00 | $450,000 | 2026 Apr 1 |
| Farrell Michael J. | Chairman and CEO | Sell | 4,991 | $251.03 | $1.3M | 2026 Mar 9 |
| Farrell Peter C | Director | Sell | 2,000 | $260.22 | $520,440 | 2026 Mar 4 |
| Sandercock Brett | Chief Financial Officer | Sell | 1,000 | $254.30 | $254,300 | 2026 Mar 2 |
| Farrell Michael J. | Chairman and CEO | Sell | 4,991 | $251.41 | $1.3M | 2025 Dec 8 |
| Farrell Peter C | Director | Sell | 2,000 | $251.47 | $502,940 | 2025 Dec 3 |
| Rider Michael J | Global General Counsel | Sell | 50 | $244.16 | $12,208 | 2025 Dec 1 |
| Sandercock Brett | Chief Financial Officer | Sell | 1,000 | $244.16 | $244,160 | 2025 Dec 1 |
| De Witte Jan | Director | Sell | 2,055 | $255.00 | $524,025 | 2025 Nov 25 |
| Farrell Peter C | Director | Sell | 2,000 | $252.05 | $504,100 | 2025 Nov 12 |
| De Witte Jan | Director | Sell | 487 | $250.25 | $121,872 | 2025 Nov 11 |
| Farrell Michael J. | Chairman and CEO | Sell | 8,011 | $249.75 | $2.0M | 2025 Nov 7 |
| Sandercock Brett | Chief Financial Officer | Sell | 3,000 | $247.54 | $742,620 | 2025 Nov 3 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $35.28 | 47.1 | $29.6B |
| | $174.34 | 51.8 | $89.9B |
| | $90.19 | 55.1 | $52.0B |
| | $372.55 | 49.7 | $131.6B |
| | $90.82 | 63.9 | $34.3B |
Take RMD further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put RMD in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when ResMed Inc. next reports.
Set alerts on RMD
Get notified when ResMed Inc. hits your price targets or technical conditions are met.
Get Started Free